- Home
- SPHR vs ANIP Comparison
SPHR vs ANIP Comparison
Compare SPHR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHR
- ANIP
- Stock Information
- Founded
- SPHR 2020
- ANIP 2001
- Country
- SPHR United States
- ANIP United States
- Employees
- SPHR N/A
- ANIP N/A
- Industry
- SPHR Services-Misc. Amusement & Recreation
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- SPHR Consumer Discretionary
- ANIP Health Care
- Exchange
- SPHR Nasdaq
- ANIP Nasdaq
- Market Cap
- SPHR 2.1B
- ANIP 2.0B
- IPO Year
- SPHR N/A
- ANIP N/A
- Fundamental
- Price
- SPHR $58.68
- ANIP $94.82
- Analyst Decision
- SPHR Buy
- ANIP Strong Buy
- Analyst Count
- SPHR 8
- ANIP 7
- Target Price
- SPHR $55.13
- ANIP $99.14
- AVG Volume (30 Days)
- SPHR 991.2K
- ANIP 270.9K
- Earning Date
- SPHR 11-11-2025
- ANIP 11-07-2025
- Dividend Yield
- SPHR N/A
- ANIP N/A
- EPS Growth
- SPHR N/A
- ANIP N/A
- EPS
- SPHR N/A
- ANIP N/A
- Revenue
- SPHR $1,040,932,000.00
- ANIP $747,399,000.00
- Revenue This Year
- SPHR $9.94
- ANIP $39.51
- Revenue Next Year
- SPHR $9.84
- ANIP $9.58
- P/E Ratio
- SPHR N/A
- ANIP N/A
- Revenue Growth
- SPHR 1.37
- ANIP 38.68
- 52 Week Low
- SPHR $23.89
- ANIP $52.50
- 52 Week High
- SPHR $68.00
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- SPHR 52.21
- ANIP 61.45
- Support Level
- SPHR $59.65
- ANIP $87.60
- Resistance Level
- SPHR $63.49
- ANIP $92.56
- Average True Range (ATR)
- SPHR 2.99
- ANIP 2.43
- MACD
- SPHR -0.86
- ANIP 0.03
- Stochastic Oscillator
- SPHR 16.29
- ANIP 96.50
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.